We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
67 result(s) found, displaying 61 to 67
-
Prescription medicine registrationActive ingredients: regdanvimab.
-
Designation or determinationProvisional approval
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HERZUMA trastuzumab (rch) 150 mg powder for injection for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUXIMA rituximab (rch) 100 mg/ 10 mL concentrate solution for intravenous infusion.
-
Australian public assessment report (AusPar)Australian Public Assessment for Rituximab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REMSIMA infliximab (rmc) 100mg Powder for Injection vial.